Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

Dr. Sanjay Ramakrishnan, lead author of the ABRA trial, highlighted the urgent need for advanced COPD treatments, calling the study a significant step forward. Geoffrey Pointing, 77, who took part ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, antibiotics and other drugs to manage the sometimes debilitating symptoms. However, ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

3] we know very little about the end-of-life care needs of people with advanced, progressive chronic illnesses such as chronic obstructive pulmonary disease (COPD). [4] As COPD progresses ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

COPD is a serious yet preventable disease, and early intervention can preserve lung function and overall well-being.

A breast cancer drug - which keeps the disease stable for up to four times longer than the previous treatment - will be ... for people with a type of advanced non-small cell lung cancer ...

Chronic obstructive pulmonary disease (COPD) is a progressive and ultimately fatal chronic illness that is the fourth leading cause of death in the world. People with advanced COPD experience ...